Canadian Wheat Board prepares for corporate takeover
"Under a sort of reverse-nationalization plan now taking shape behind closed doors, a private-sector investor will assume control without reimbursing the federal treasury for assets Canadians paid for, or at least indirectly financed."
No amount of legislative reversal will undo the transfer of assets and control of the CWB into private hands, at least not without nationalization of the agency. This is another one of Harpe...r's efforts to give a degree of permanency to policy decisions, such as including punitive measures in FIPA, executed under Royal Proclamation.
"Under a sort of reverse-nationalization plan now taking shape behind closed doors, a private-sector investor will assume control without reimbursing the federal treasury for assets Canadians paid for, or at least indirectly financed."
No amount of legislative reversal will undo the transfer of assets and control of the CWB into private hands, at least not without nationalization of the agency. This is another one of Harpe...r's efforts to give a degree of permanency to policy decisions, such as including punitive measures in FIPA, executed under Royal Proclamation.
http://www.cbc.ca/news/politics/canadian-wheat-board-prepares-for-corporate-takeover-1.2853874
_____________________________________________________________________
Lets not forget this fabulous screw up sale to a known corrupt firm.....
Canada sells nuclear energy firm to SNC-Lavalin
It is paying $15 million for AECL's Candu reactor sales and service division, which is being split from its Chalk River research laboratory and reactor used for producing medical isotopes, which Ottawa will continue to own.
As well, Ottawa will receive royalties from the future sales of reactors through a licensing agreement.
Ottawa had been looking to dump AECL after sinking $2.5 billion dollars into failed research and development, and support for its commercial sales over the past five years.
"This is the best deal in a difficult domestic and international environment," said Oliver. "It does preserve the CANDU business, which has been in a challenging situation, and allows Canadians to benefit from its future success."
An Ontario pension fund earlier this year walked away from jointly purchasing AECL with SNC-Lavalin, as Japan's woes dimmed the market prospects for new nuclear plants
The Ontario Municipal Employees Retirement System would have brought financial heft to the partnership, offering buyers loan guarantees for reactor purchases and assuming cost overruns.
But it was reportedly concerned that SNC-Lavalin did not have a long-term vision of the nuclear business, and that the disaster in Japan would further hinder the market.
According to reports, SNC-Lavalin is expected to focus on servicing and refurbishing AECL's existing Candu reactors and not introduce new product lines.
http://www.globalenergywatch.com/news/984/Canada_sells_nuclear_energy_firm_to_SNC-Lavalin.htm
_________________________________________________________________________
And yes this is yet another incompetent deal with.......
"Delays of this kind suggest it would be foolhardy to entrust NewLink, which owns no large-scale manufacturing plant and which has never commercialised a product, with manufacturing this vaccine. Africa's needs are too urgent for half measures."
Is Canada patent deal obstructing Ebola vaccine development?
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2962044-4/fulltext
However, rather than put this invention in the public domain, Canada's Minister of Health applied to patent the vaccine.3 Canada subsequently granted Bioprotection Systems Corporation, a subsidiary of NewLink Genetics, a “sole, worldwide, revocable and royalty-bearing license” to develop and commercialise the vaccine “for the maximum commercial return to the Company and Canada”.4 This profit-driven arrangement does not put public health first.
_____________________________________________________________________
Lets not forget this fabulous screw up sale to a known corrupt firm.....
Canada sells nuclear energy firm to SNC-Lavalin
It is paying $15 million for AECL's Candu reactor sales and service division, which is being split from its Chalk River research laboratory and reactor used for producing medical isotopes, which Ottawa will continue to own.
As well, Ottawa will receive royalties from the future sales of reactors through a licensing agreement.
Ottawa had been looking to dump AECL after sinking $2.5 billion dollars into failed research and development, and support for its commercial sales over the past five years.
"This is the best deal in a difficult domestic and international environment," said Oliver. "It does preserve the CANDU business, which has been in a challenging situation, and allows Canadians to benefit from its future success."
An Ontario pension fund earlier this year walked away from jointly purchasing AECL with SNC-Lavalin, as Japan's woes dimmed the market prospects for new nuclear plants
The Ontario Municipal Employees Retirement System would have brought financial heft to the partnership, offering buyers loan guarantees for reactor purchases and assuming cost overruns.
But it was reportedly concerned that SNC-Lavalin did not have a long-term vision of the nuclear business, and that the disaster in Japan would further hinder the market.
According to reports, SNC-Lavalin is expected to focus on servicing and refurbishing AECL's existing Candu reactors and not introduce new product lines.
http://www.globalenergywatch.com/news/984/Canada_sells_nuclear_energy_firm_to_SNC-Lavalin.htm
_________________________________________________________________________
And yes this is yet another incompetent deal with.......
"Delays of this kind suggest it would be foolhardy to entrust NewLink, which owns no large-scale manufacturing plant and which has never commercialised a product, with manufacturing this vaccine. Africa's needs are too urgent for half measures."
Is Canada patent deal obstructing Ebola vaccine development?
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2962044-4/fulltext
However, rather than put this invention in the public domain, Canada's Minister of Health applied to patent the vaccine.3 Canada subsequently granted Bioprotection Systems Corporation, a subsidiary of NewLink Genetics, a “sole, worldwide, revocable and royalty-bearing license” to develop and commercialise the vaccine “for the maximum commercial return to the Company and Canada”.4 This profit-driven arrangement does not put public health first.
No comments:
Post a Comment